Zephyr Valves are a standard of care treatment option for patients with severe #COPD/#emphysema. Learn more: https://bit.ly/3zC3dQF #COPDSupport #Lung #Pulmonology #Respiratory #LungHealth #BreatheBetter
Pulmonx Corporation
Medical Equipment Manufacturing
Redwood City, CA 15,437 followers
Improving Breathing and Quality of Life for Emphysema and Advanced COPD Patients
About us
Pulmonx has developed the Zephyr Endobronchial Valve, a minimally invasive treatment for COPD/emphysema. The one-time procedure is done by bronchoscopy and requires no cutting or incisions. During the procedure, on average 4 tiny valves are placed in the airways to block off the diseased parts of the lung which allows trapped air to escape until the lobe is reduced. Reducing hyperinflation allows the healthier parts of the lungs to expand and take in more air. This results in patients being able to breathe easier and have less shortness of breath.1 Complications of the Zephyr Endobronchial Valve treatment can include but are not limited to pneumothorax, worsening of COPD symptoms, hemoptysis, pneumonia, dyspnea and, in rare cases, death.1 1. Criner G et al AM J Resp Crit Care Med 2018, Published on 22-May-2018 as 10.1164/rccm.201803-0590OC Brief Statement: The Pulmonx Zephyr® Endobronchial Valves are implantable bronchial valves indicated for the bronchoscopic treatment of adult patients with hyperinflation associated with severe emphysema in regions of the lung that have little to no collateral ventilation. The Zephyr Valve is contraindicated for: Patients for whom bronchoscopic procedures are contraindicated; those with evidence of active pulmonary infection; known allergies to Nitinol (nickel-titanium) or its constituent metals (nickel or titanium); known allergies to silicone, or with large bullae encompassing greater than 30% of either lung; Patients who have not quit smoking. The Zephyr Valve should be used with caution and only after careful consideration in treating patients with: Prior lung transplant, LVRS, median sternotomy, or lobectomy; Congestive heart failure or recent myocardial infarction; FEV1 <15% of predicted value. Use is restricted to a trained physician. Prior to use, please reference the Zephyr Endobronchial Valve System Instructions for more information on indications, contraindications, warnings, all precautions, and adverse events.
- Website
-
http://www.Pulmonx.com
External link for Pulmonx Corporation
- Industry
- Medical Equipment Manufacturing
- Company size
- 201-500 employees
- Headquarters
- Redwood City, CA
- Type
- Privately Held
- Specialties
- Medical Device, Interventional Pulmonology, Emphysema Treatment, and Endobronchial Valve Therapy
Locations
-
Primary
700 Chesapeake Drive,
Redwood City, CA 94063, US
-
Rue de la Treille 4
Neuchâtel, 2000, CH
Employees at Pulmonx Corporation
Updates
-
Studies show that Zephyr Valves improve health status and quality of life for patients with severe #COPD/#emphysema. With an increase in lung function and decrease of trapped air, the Zephyr Valves may help your patients get back to their favorite daily activities. Learn more: https://bit.ly/46YYmWe #MedicalDevice #ZephyrByPulmonx #MedTech #Bronchology
-
-
With a GOLD 2023: Level A Evidence rating, the Zephyr Valves are a viable treatment for patients with severe #COPD/#emphysema. Learn more about the Zephyr Valves and patient selection here: https://bit.ly/3VSFqEW
-
-
BLVR impact on cardiac function: A single-center, non-randomized, prospective study showed significant clinical improvements in cardiac preload, myocardial contractility and cardiac output for patients with severe #COPD/#emphysema without a history of cardiovascular disease.* Read more: https://bit.ly/3ESBsTD #BLVR #Bronchoscopy #MedDevice #Pulmonology
-
-
Pulmonx Corporation reposted this
Our 2nd Annual Advanced Clinical Summit was a tremendous success! This year’s event gathered dedicated professionals, passionate about advancing patient care in the field of BLVR. Attendees participated in a comprehensive curriculum designed to identify patients most likely to benefit from our interventions, build efficient patient pathways, and engage administration to secure necessary resources. It was incredibly exciting to witness the camaraderie and shared purpose as we work together to build the next generation of BLVR programs. I am truly humbled to collaborate with the exceptional physicians and staff at Zephyr Valve treating centers, united in our mission to fight for every breath so that COPD patients don’t have to. Together, we are making a difference, one breath at a time! Bobby Mahajan MD, FCCP, DAABIP Medical Director, Inova Interventional Pulmonology Jonathan Kurman Deborah Stahlnecker Bunn Jill Josiebeth Rivera Melendez Ahmed Khan Mark Vollenweider Narinder Singh Shargill, PhD #AdvancedClinicalSummit #BLVR #COPD #ZephyrValve #HealthcareInnovation #ForEveryBreath
-
-
Your patients with severe COPD/emphysema deserve to know about all available treatment options. Check out the Zephyr Valve Video Hub – a YouTube channel to learn more about how endobronchial valves may help patients breathe easier. Dedicated to educational content for healthcare professionals, our new channel provides on-demand videos. Hear directly from your peers, see how treated patients are thriving, learn about patient screening — and much more. Visit and subscribe to get notifications when new content drops: https://bit.ly/41MEQIP #ZephyrValve #BLVR #pulmonologists #EndobronchialValves
-
Pre & Post procedure X-ray image of a 59-year-old male with FEV₁ shows his improvements. He is back to being able to complete yard work and house chores. The Zephyr Endobronchial Valves are designed to reduce hyperinflation of the lungs caused by severe COPD/emphysema and are a minimally invasive option that may improve patient's lung function, exercise capacity, and quality of life. See the full case spotlight here: https://bit.ly/3RgWT7m Important Safety Information: https://bit.ly/3RknwbE
-
-
Healthcare providers know firsthand how difficult it can be to find a treatment plan that works for severe #COPD/#emphysema patients. The Zephyr Valve is a minimally invasive treatment, where tiny one-way valves are placed in the diseased part of the lung to reduce air trapped in that lobe, so the healthier parts of the lung can function better. Learn more: https://bit.ly/3KxC6Zp
-
-
Zephyr Valves are a standard-of-care treatment option for patients with severe #COPD/#emphysema. Learn more: https://bit.ly/3RfsIgJ #COPDSupport #Lung #Pulmonology #Respiratory #LungHealth #BreatheBetter
Learn More
-
The Global Initiative for Chronic Obstructive Lung Disease 2023 Report has summarized the growing body of evidence from clinical studies on the efficacy of #Endobronchial Valves to treat severe #COPD/#emphysema. The patient benefits reported in the GOLD 2023 Report include: • Improved survival after successful treatment (4 retrospective studies) • Sustained and significant quality of life improvements • Decreased complications that may lead to hospitalization • May delay need for lung transplant #Endobronchial Valves have been included in the GOLD Report since 2017, as part of the standard of care for treating severe #COPD/#emphysema. Every year, more clinical evidence has been added to the GOLD Report to show how this treatment improves lung function and quality of life for patients who receive this treatment. Learn more about the key evidence and read the GOLD 2023 Report section on Endobronchial Valves: https://bit.ly/3IO4PJA #BLVR #ZephyrValves #GOLD #Pulmonology #COPD
-